Target Group (Target Group) EBIT

: $1.09 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

Target Group's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was $0.17 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.09 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Target Group's annualized ROC % for the quarter that ended in Dec. 2023 was 4.67%. Target Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 12.12%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Target Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 23.51%.

Target Group EBIT Historical Data

The historical data trend for Target Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Target Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

-9.90

-6.53

1.26

-3.40

1.09

Target Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT																-3.63	-0.39	1.33	-0.02	0.17

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Target Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Target Group EV-to-EBIT Distribution

For the Drug Manufacturers industry and Healthcare sector, Target Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Target Group's EV-to-EBIT falls into.

Target Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.09 Mil.

Target Group (OTCPK:CBDY) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Target Group's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	0.276 * ( 1 - 0% )	/	( (5.886	+	5.926)	/ 2 )
=	0.276	/	5.906
=	4.67 %

where

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	8.327	-	8.267	-	( 0.445	-	max(0, 8.411	-	2.585	+	0.445	))
=	5.886

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	8.841	-	14.41	-	( 0.736	-	max(0, 14.589	-	3.094	+	0.736	))
=	5.926

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Target Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	0.664	/	( ( (5.478 + max(-6.22, 0))	+	(5.477 + max(-12.106, 0)) )	/	2 )
=	0.664	/	( ( 5.478	+	5.477 )	/	2 )
=	0.664	/	5.4775
=	12.12 %

where Working Capital is:

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.128	+	1.893	+	0.05)	-	(8.267	+	0	+	0.024000000000001)
=	-6.22

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1.032	+	1.216	+	0.107)	-	(14.41	+	0.043	+	0.0080000000000009)
=	-12.106

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Target Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	1.088	/	4.627
	=	23.51 %

Target Group EBIT Related Terms

Thank you for viewing the detailed overview of Target Group's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Target Group (Target Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Target Group Inc (OTCPK:CBDY) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

20 Hempstead Drive, Hamilton, ON, CAN, L8W 2E7

Website

https://www.targetgroupinc.ca

Target Group Inc is engaged in the cultivation, processing, and distribution of curated cannabis products for the adult-use medical and recreational cannabis market in Canada. The company generates revenue from the sale of Wisp vaporizer and pod units.

Executives

Barry Alan Katzman	director	36 ADDISON DRIVE, ST. CATHERINES A6 L2S 4B7
Anthony Carlo Zarcone	director	564 NORTH SHORE BLVD., BURLINGTON A6 L7T 1X2
Frank Michael Monte	director	18 BRAESIDE SQ, MARKHAM A6 L3R 0A5
Saul Niddam	director	42 HEATHVIEW AVE, NORTH YORK A6 M2K 2C1
Azmatali Mehrali	officer: CFO	134 BRIDGEPOINTE COURT, AURORA A6 L4H 3H8
Alexander Starr	director, 10 percent owner, officer: President	1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Rubin Schindermann	director, 10 percent owner, officer: CEO	1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Weinstein Family (2015) Trust	10 percent owner	52 RIDOUT STREET EAST, TILLSONBURG A6 N4G 2E3
Chess Supersite Inc. (canada)	10 percent owner	1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
Nava Starr	other: See Remarks	1131A LESLIE STREET, SUITE 101, TORONTO A6 M3C 3L8
James M Cassidy	director, 10 percent owner, officer: president	215 APOLENA AVENUE, NEWPORT BEACH CA 92662
James K Mckillop	director, 10 percent owner, officer: vice president	9454 WILSHIRE BOULEVARD, SUITE 612, BEVERLY HILLS CA 90212